DMI-Logo
search-iconsearch-icon

Neurology Research Reports & Consulting

Home
>
Reports
>
Pharmaceuticals
>
Neurology
Browse reports
DataM has exclusive market relevance and knowledge catering our services in 60+ industries
SUB CATEGORIES
All PharmaceuticalsCardiovascularCentral Nervous SystemDermatologyEar Nose Throat DisordersGastrointestinalGenitourinary DisordersHematologyHormonal DisordersImmunologyInfectious DiseaseMetabolic DisorderDiabetes CareMouth And Dental DisordersPain ManagementMusculoskeletalNeurologyNon-Malignant DisordersNutritional DisordersOncologyOphthalmologyOther DiseasesAllergyRespiratoryWomen's and Male HealthWound Care TreatmentSyndromeOthers
FILTER
Geography
Publish Date
Themesdown
SORT
Upload Date
Upload Date
Price
Published: 2026 September 29
Alzheimer’s Disease Therapeutics Market Size, Share Analysis, Growth, Report 2026-2033
Alzheimer’s Disease Therapeutics Market size was at US$ 5.38 billion in 2025 and is expected to reach US$ 17.98 billion by 2033, growing at a CAGR of 14.32%.
Starting from
$4350$2999
Published: 2026 September 28
Drug-Resistant Epilepsy Market Size, Share, Industry, Forecast and Outlook (2026-2033)
Global Drug Resistant Epilepsy Market reached US$ 0.89 billion in 2025 and is expected to reach US$ 1.28 billion by 2033, growing with a CAGR of 4.4% during the forecast period 2026-2033.
Starting from
$4350$2999
Published: 2026 September 19
Ataxia Market for Friedreich Ataxia, Spinocerebellar Ataxias, Gene Therapy and Rare-Neurology Care 2026-2035
The ataxia market reached US$ 2.38 billion in 2025 and is projected to reach US$ 6.71 billion by 2035, growing at 10.9% CAGR as Friedreich ataxia therapies, genetic testing, RNA treatments, protein replacement and gene therapy pipelines advance.
Starting from
$4350$2999
Published: 2026 September 12
Cognitive Nootropics Market Size, Share, Trends and Forecast 2026-2035
Cognitive nootropics market reached US$ 4.72 billion in 2025 and is projected to reach US$ 12.87 billion by 2035, growing at a 10.6% CAGR during 2026-2035.
Starting from
$4350$2999
Published: 2026 September 10
Cholinergic Drugs Market for M1/M4 Antipsychotics, Dementia Therapy and Receptor-Targeted CNS Treatment 2026-2035
Cholinergic Drugs Market Outlook for Dementia, Schizophrenia and Muscarinic Therapies
Starting from
$4350$2999
Published: 2026 September 08
Neurotherapeutics Market Size, Neurological Drugs and Devices Forecast 2033
Explore the Neurotherapeutics Market by neurological drugs, neurostimulation devices, Alzheimer’s disease, Parkinson’s disease, epilepsy, multiple sclerosis, end users and key players. Download a free sample or request an enquiry for detailed market insights.
Starting from
$4350$2999
Published: 2026 September 03
Acute Migraine Drugs Market Size, Share, Industry, Forecast and outlook (2026-2033)
Acute Migraine Drugs Market reached US$ 12.8 billion in 2025 and is expected to reach US$ 23.5 billion by 2033 growing with a CAGR of 8.1% during the forecast period 2026-2033.
Starting from
$4350$2999
Published: 2026 August 28
Idiopathic Hypersomnia Treatment Market Size, Share, Industry, Forecast and Outlook (2026-2033)
The Idiopathic Hypersomnia Treatment Market is expected to grow at a CAGR of 8.9% during the forecast period 2026-2033 | DataM Intelligence
Starting from
$4350$2999
Published: 2026 August 25
Anti-Amyloid Monoclonal Antibodies Market Size, Share Analysis, Growth Trends and Forecast 2026-2033
Anti-Amyloid Monoclonal Antibodies Market reached US$ 0.64 billion in 2025 and is expected to reach US$ 6.71 billion by 2033
Starting from
$4350$2999
Published: 2026 August 17
Krabbe Disease Treatment Market Size, Share, Industry, Forecast and outlook (2026-2033)
The global Krabbe disease treatment market was valued at approximately USD 262.25 million in 2025 and is projected to reach nearly USD 786.45 million by 2033, growing at a CAGR of 16.8% during the forecast period from 2026 to 2033.
Starting from
$4350$2999